Erythema Multiforme, Stevens–Johnson Syndrome, and Toxic Epidermal Necrolysis

16


Erythema Multiforme, Stevens–Johnson Syndrome, and Toxic Epidermal Necrolysis




Erythema Multiforme



Self-limited, but potentially recurrent, disease.


Two forms: erythema multiforme (EM) major and EM minor (Table 16.1).



Both forms have an abrupt onset of papular ‘target’ lesions that favor acrofacial sites.


Two types of target lesions: (1) typical targets, with at least three different zones; (2) atypical papular targets, with only two different zones and/or a poorly defined border (Fig. 16.1).



EM minor: typical > atypical papular target lesions, little or no mucosal involvement, and no systemic symptoms.


EM major: typical > atypical papular target lesions, moderate to severe mucosal involvement, and some systemic symptoms (fever, asthenia, arthralgia).


Preceding HSV infection is most common precipitating factor; less often other preceding infections, in particular Mycoplasma pneumoniae (Table 16.2; Fig. 16.2); rarely drug exposure.




Diagnosis based on clinicopathologic correlation and not solely histopathologic findings.


EM is a distinct disorder from Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) (see Table 16.1).


EM does not progress to TEN.


DDx: giant urticaria (Fig. 16.3; Table 16.3), morbilliform drug reaction (Fig. 16.4), multiple fixed drug eruption (FDE), acute hemorrhagic edema of infancy, Kawasaki disease, small vessel vasculitis, Rowell’s syndrome, GVHD, polymorphic light eruption (PMLE).


Apr 22, 2016 | Posted by in Dermatology | Comments Off on Erythema Multiforme, Stevens–Johnson Syndrome, and Toxic Epidermal Necrolysis

Full access? Get Clinical Tree

Get Clinical Tree app for offline access